Transcriptional activity of genes encoding interferon γ (IFNγ) and its receptor assessed in peripheral blood mononuclear cells in patients with cardiac syndrome X

Inflammation

Volumn 30, Issue 3-4, 2007, Pages 125-129

  Dabek, Jozefa ^a   Kulach, Andrzej ^a   Wilczok, Tadeusz ^a   Mazurek, Urszula ^a   Jakubowski, Daniel ^a   Gasior, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cardiac syndrome X; Gene expression; Interferon gamma; Interferon receptor

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; MESSENGER RNA;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIAC SYNDROME X; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MICROVASCULATURE; PATHOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION INITIATION;

ADULT; AGED; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; NEUROPEPTIDES; RECEPTORS, INTERFERON; TRANS-ACTIVATION (GENETICS);

EID: 34250852902     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-007-9028-0     Document Type: Article

References (21)

1. Kemp, H. G. 1973. Left ventricular function in patients with the anginal syndrome and normal coronary angiograms. Am. J. Cardiol. 32:375-376.
2. Panting, J. R., P. D. Gatehause, G. Z. Yang, and F. Grothues. 2002. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N. Engl. J. Med. 346:1948-1953.
3. Tymińska-Sȩdek K., and M. Jakubowska-Najnigier. 2002., Chory z kardiologicznym zespołem X. Terapia. 9(2):41-47.
4. Rogacka D., and H. Wysocki. 2003. Dławica mikronaczyniowa i zaburzenia percepcji bólu jako główne składowe patogenetyczne kardiologicznego zespołu X. Folia Cardiol. 10:553-561.
5. Kaski J. C., G. M. Rosano, and P. Collins. 1995. Cardiac syndrome X: Clinical characteristics and left ventricular function long-term follow-up study. JACC 25:807-814.
6. Johnson B. D. et al. 2004. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institutes-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109:2993-2999.
7. Kołodziej K., and J. D. Kasprzak. 2001. Kardiologiczny zespół X. Forum Kardiol. 4:1425-3674.
8. Vazquez-Rey E., and J. C. Kaski. 2003. Cardiovascular syndrome X and endothelial dysfunction. Rev. Esp. Cardiol. 56:181-192.
9. Leu H. B., C. P. Lin, W. T. Lin, T. C. Wu, S. J. Lin, and J. W, Chen. 2006. Circulating mononuclear superoxide production and inflammatory markers for long-term prognosis in patients with cardiac syndrome X. Free Radic. Biol. Med. 40:983-991.
10. Zhang P., Z. Chen, F. Chen, M. Li, J. Fan, H. Zhou, J. Liu, and Z. Huang. 2004. Expression of IFN-γ and its receptor alpha in the peripheral blood of patients with chronic hepatitis C. Chin. Med. J. 117(1):79-82.
11. Deb, D. K., A. Sassano, F. Lekmine, B. Majchrzak, A. Verma, S. Kambhampat, S. Uddin, A. Rahman, E. N. Fis, and L. C. Platanias. 2003. Activation of Protein Kinase CD by IFN. J. Immunol. 171:267-273.
12. Allione A., P. Bernabei, M. Bosticardo, S. Ariotti, S. Forni, and F. Novell. 1999. Nitric oxide suppresses human T lymphocyte proliferation through IFN-γ-dependent and IFN-γ-independent induction of apoptosis. J. Immunol. 163:4182-4191.
13. Pestka, S. 1997. The interferon receptors. Semin. Oncol. 24:S9-18-S9-40 (Jun).
14. Haus O. 2000. The genes of interferons and interferon-related factors: Localization and relationships with chromosome aberrations in cancer. Arch. Immunol. Ther. Exp. 48:95-100.
15. Robertson B., X. J. Xu, J. X. Hao, Z. Wiesenfeld-Hallin, J. Mhlanga, G. Grant, and K. Kristensson. 1997. Interferon-gamma receptors in nociceptive pathways: role in neuropathic pain-related behaviour. NeuroReport. 8:1311-1316.
16. Fernandes J. L., R. L. Mamoni, J. L. Orford, C. Garcia, A. P. Selwyn, O. R. Coelho, and M. H. Blotta. 2004. Increased Th1 activity in patients with coronary artery disease. Cytokine. 26(3):131-137 (May 7).
17. Reiss A. B., C. A. Patel, M. M. Rahman, E. S. Chan, K. Hasneen, M. C. Montesinos, J. D. Trachman, and B. N. Cronstein. 2004. Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages. Med. Sci. Monit. 10:BR420-BR425.
18. Inagaki Y., S. Yamagishi, S. Amano, T. Okamoto, K. Koga, and Z. Makita. 2002. Interferon-gamma-induced apoptosis and activation of THP-1 macrophages. Life Sci. 71:2499-2508.
19. Koh K. P., Y. Wang, T. Yi, S. L. Shiao, M. I. Lorber, W. C. Sessa, G. Tellides, and J. S. Pober. 2004. T cell-mediated vascular dysfunction of human allografts results from IFN-γ dysregulation of NO synthase. J. Clin. Invest. 114:846-856, September 15.
20. Lin C. P., W. T. Lin, H. B. Leu, T. C. Wu, and J. W. Chen. 2003. Differential mononuclear cell activity and endothelial inflammation in coronary artery disease and cardiac syndrome X. Int. J. Cardiol. 89:53-62.
21. Hartrick C. T. 2002. Increased production of nitric oxide stimulated by interferon-gamma from peripheral blood monocytes in patients with complex regional pain syndrome. Neurosci Lett. 323:75-77.